Resources from the same session
Decision making in post-neoadjuvant setting: The role of pCR, RCB, ctDNA, TILs and molecular features
Presenter: Carsten Denkert
Session: Post neoadjuvant systemic treatment decisions
Resources:
Slides
Webcast
Triple negative breast cancer (TNBC): Is there a standard treatment and does one size fit all?
Presenter: Helena Earl
Session: Post neoadjuvant systemic treatment decisions
Resources:
Slides
Webcast
HER2-positive: De-escalation and escalation strategies
Presenter: Evandro de Azambuja
Session: Post neoadjuvant systemic treatment decisions
Resources:
Slides
Webcast
HR-positive/HER2-negative: When to use CDK4/6 inhibitors, including gBRCA1/2mut patients?
Presenter: Carmen Criscitiello
Session: Post neoadjuvant systemic treatment decisions
Resources:
Slides
Webcast